logo
    The Effect of Interpersonal Psychotherapy on Quality of Life Among Breast Cancer Patients With Common Mental health Disorder: A Randomized Control Trial At Tikur Anbessa Specialized Hospital
    1
    Citation
    30
    Reference
    10
    Related Paper
    Citation Trend
    Abstract:
    Abstract Purpose: To determine the effect of interpersonal psychotherapy on anxiety, depression, and quality of life among breast cancer patients with mental health disorders at Tikur Anbessa Specialized Hospital, Ethiopia. Methods: A two-arm parallel randomized controlled trial study was conducted among 114 (n=57 intervention, and n= 57 control group) breast cancer patients with common mental health disorder at the oncology center of Tikur Anbessa Specialized Hospital. The hospital anxiety and depression measurement scale was used to assess depression and anxiety disorder and a 30-item quality of life questionnaire was used to assess the quality of life. General Linear Model analysis was done, confounding factors were controlled, and P<0.05 was used to declare statistical significance. Results: Patients in the intervention group showed a significant improvement in the anxiety (coefficient -3.68; 95% CI -5.67,-1.69; P<0.001), depression (coefficient -3.22; 95% CI -4.7,-1.69; P<0.001), physical functioning (coefficient 10.55; 95% CI 3.13, 17.98; P=0.006), health related quality of life (coefficient 21.85; 95% CI 14.1, 29.59; P<0.001), Insomnia (coefficient -19.56; 95% CI -31.87, -7.25; P=0.002), and fatigue (coefficient -11.37; 95% CI -21.49, -1.24; P=0.028) respectively. Conclusions: The adapted Ethiopian version of interpersonal psychotherapy had improved anxiety, depression, and some domains of health-related quality of life. Hence, health programmers should consider incorporating it as a treatment option in oncology centers. Trial registration number: PACTR202011629348967 granted on 20 November 2020 which was retrospectively registered.
    Keywords:
    Depression
    ABSTRACT Background: It is not uncommon that anxiety and depression occur in patients with cancers, and past researches have shown that the quality of life of patients is negatively affected. This study aims to determine the prevalence of anxiety and depression of patients with haematological cancers in Malaysia and to investigate the possible association of these psychological symptoms with their quality of life. Methods: This is a cross-sectional study where patients with haematological cancers attending two major hospitals were recruited. Anxiety and depression symptoms were assessed using the Hospital Anxiety and Depression scale (HADS). Quality of life (QoL) of these patients was measured using the European Organisation for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ C30). An overall summary QoL score in combination with financial difficulty score and global health score were used for analysis. Results: A total of 319 patients were recruited. Thirty-three percent of patients had anxiety symptoms, 23.5% had depression symptoms. In summary the overall score of QoL is significantly lower in patients with higher scores for depression and anxiety, (p<0.05). Patients who exhibit anxiety symptoms were more frequently female, still undergoing treatment whereas patients who had higher depression scores were older and had acute leukemias or myeloproliferative neoplasms. Patients who have depression are significantly associated with a higher financial difficulty score, p<0.05. Conclusion: The poor quality of life in patients who have anxiety and depression should raise awareness amongst the health professions treating them so that additional support can be provided.
    Depression
    Citations (0)
    A prospective study was conducted to measure anxiety and depression in Iranian breast cancer patients before and after diagnosis using the Hospital Anxiety and Depression Scale (HADS). The HADS was administered at two points in time: before diagnosis and 3 months after. In all, 168 breast cancer patients were interviewed. While 48% of patients had severe symptoms of anxiety at both baseline and follow-up, more than 60% of patients had no symptoms of depressive illness at pre-and post-diagnosis assessments. Comparing anxiety and depression before diagnosis and after 3 months, there were no significant differences between patients' scores on anxiety (P = 0.42) and depression (P = 0.98) subscales. The results showed that patients with advanced disease and a lower performance status were more anxious and experienced more depression. The study findings suggest that severe symptoms of anxiety are the most frequent symptoms in Iranian breast cancer patients. It seems that during the process of diagnosis and 3 months after psychological morbidity persists in patients who suffer from breast cancer.
    Depression
    Objective:To evaluate the status of anxiety and depression of patients with breast cancer,and analyze the related factors.Methods:The self-rating anxiety scale,self-rating depression scale and a self-designed questionnaire were used to investigate 230 patients with breast cancer.Results:The incidence of anxiety and depression in patients with breast cancer were 56.09% and 49.57% respectively.The related factors included age,educational level,pay forms,the monthly income of family and tumor staging and so on.Conclusions:The incidences of anxiety and depression of patients with breast cancer are relatively higher.To improve the psychological state of them,psychological intervention should be strengthened in the perioperative period of patients with breast cancer.
    Depression
    Citations (1)
    Objective To explore the comprehensive community intervention on the impact of depression and anxiety in patients with breast cancer. Methods 112 cases of breast cancer patients were randomly divided into treatment group(n =56 and control group(n=56). Treatment group given to the same time withbiological-psychological-socialfactors in the three intervention integrated intervention,while others are the control group. All patients with breast cancer were investigated with SAS and SDS before treatment,after 6 months,12 months. Results After 1 year,depression and anxiety in patients with significantly improved. The differences before and after intervention was statistically significant(t=4.055,5.540;P0.01),and the differences between Treatment group and the control group was statistically significant(t =-4.093,-4.836,P 0.01). Conclusion Comprehensive community intervention can significantly improve depression and anxiety in patients with breast cancer. The degree of improvement is proportional to time and the treatment time of 12 months for the best.
    Depression
    Citations (0)
    It is not uncommon that anxiety and depression occur in patients with cancers, and past researches have shown that the quality of life of patients is negatively affected. This study aims to determine the prevalence of anxiety and depression of patients with haematological cancers in Malaysia and to investigate the possible association of these psychological symptoms with their quality of life.This is a cross-sectional study where patients with haematological cancers attending two major hospitals were recruited. Anxiety and depression symptoms were assessed using the Hospital Anxiety and Depression scale (HADS). Quality of life (QoL) of these patients was measured using the European Organisation for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ C30). An overall summary QoL score in combination with financial difficulty score and global health score were used for analysis.A total of 319 patients were recruited. Thirty-three percent of patients had anxiety symptoms, 23.5% had depression symptoms. In summary the overall score of QoL is significantly lower in patients with higher scores for depression and anxiety, (p<0.05). Patients who exhibit anxiety symptoms were more frequently female, still undergoing treatment whereas patients who had higher depression scores were older and had acute leukemias or myeloproliferative neoplasms. Patients who have depression are significantly associated with a higher financial difficulty score, p<0.05.The poor quality of life in patients who have anxiety and depression should raise awareness amongst the health professions treating them so that additional support can be provided.
    Depression
    Citations (5)
    Background: People who have previously used psychiatric services may be particularly vulnerable and at greater risk of mortality following a cancer diagnosis. The present study assessed depression and anxiety among breast cancer patients. Materials and Method: The present study was conducted on 64 women with breast cancer. The Patient Health Questionnaire-2 (PHQ-2) and the Generalized Anxiety Disorder-2 (GAD-2) questionnaire were produced as ultra-brief screening instruments for depression and anxiety in all patients. Results: Age group <40 years had 12, 40-60 years had 20 and >60 years had 32 patients. The difference was significant (P< 0.05). Maximum patients were of stage III (30) followed by stage II (18), stage IV (10) and stage I (6). Treatment given was mastectomy in 46 patients and ongectomy in 18 patients. The difference was significant (P< 0.05). PHQ- 2 with score >3 was observed in 12 and GAD- 2 with score >3 was seen in 15 patients. The difference found to be significant in breast cancer patients with or without depression and anxiety (P< 0.05). Conclusion: Authors found that breast cancer patients had higher level of depression and anxiety level.
    Depression
    Patient Health Questionnaire
    Citations (0)
    Introduction. Today, breast cancer patients suffer from various psychological symptoms that impose irreversible effects on their quality of life. The aim of the present study was to determine the prevalence of depression, anxiety, and stress in patients with breast cancer. Material and methods. This descriptive study was performed on 190 women with breast cancer from January 1, 2019 to July 30, 2019. Data collection was carried out using a convenience sampling method. The Standard Depression, Anxiety, and Stress Scale (DASS-21) was used to assess depression, anxiety, and stress. Results. The mean age of the patients was 46.3 years. Results showed the prevalence of depression, anxiety, and stress to be 28.4%, 43.2%, and 14.7%, respectively. Conclusion. The results indicate that it is vital to measure the level of depression and anxiety in women with breast cancer, which are two common mental disorders in breast cancer.
    Depression
    Cross-sectional study
    DASS
    Citations (8)
    Objective:To investigate the anxiety and depression of postoperative breast cancer patients,and analyse the infuential factors.Methods:SDS and SAS scales were used to investigate the psychological evaluation of postoperative breast cancer patients.Results:The anxiety and depression of postoperative breast cancer patients were significantly higher than the domestic situation of the norm,which occurred with age,income,professional and clinical stage and so on.Conclusion:Postoperative breast cancer patients had more serious depression and anxiety,and nurse should pay attention to psychological intervention of postoperative breast cancer patients.
    Depression
    Citations (0)